PhaseBio Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.7%.

Top 25 shareholders own 31.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.75%	Avidity Partners Management, L.P.	4,361,365	€12.2k	-0.99%	no data
6.03%	AstraZeneca PLC	3,004,554	€8.4k	0%	no data
5.45%	Rock Springs Capital Management LP	2,719,074	€7.6k	-2.01%	no data
4.84%	Hatteras Venture Partners	2,412,919	€6.7k	0%	0.16%
1.42%	Rosalind Advisors, Inc.	707,467	€2.0k	0%	0.04%
1.33%	BlackRock, Inc.	665,563	€1.9k	-2.72%	no data
0.65%	Dafna Capital Management, LLC	321,856	€898.9	-15%	no data
0.64%	Geode Capital Management, LLC	320,642	€895.6	0%	no data
0.4%	Bridgeway Capital Management, LLC	201,600	€563.1	59.2%	no data
0.37%	Jonathan Mow	183,701	€513.1	0%	no data
0.35%	Acadian Asset Management LLC	172,958	€483.1	-36.6%	no data
0.22%	Jane Street Group, LLC, Asset Management Arm	110,661	€309.1	-1.78%	no data
0.19%	Morgan Stanley, Investment Banking and Brokerage Investments	95,763	€267.5	-10.3%	no data
0.18%	State Street Global Advisors, Inc.	91,850	€256.5	0%	no data
0.13%	John Sharp	65,767	€183.7	0%	no data
0.12%	Snowden Capital Advisors LLC	60,800	€169.8	0%	no data
0.12%	Northern Trust Global Investments	58,119	€162.3	0%	no data
0.083%	Susan Arnold	41,236	€115.2	0%	no data
0.076%	Nancy Hutson	37,760	€105.5	0%	no data
0.076%	Northeast Financial Consultants, LLC	37,760	€105.5	0%	no data
0.075%	United Bank (Fairfax, VA), Asset Management Arm	37,400	€104.5	39%	no data
0.069%	Hamilton Lane Incorporated	34,208	€95.5	0%	no data
0.066%	Clay Thorp	32,943	€92.0	0%	no data
0.058%	IPG Investment Advisors, LLC	28,700	€80.2	-0.69%	no data
0.04%	Jonathan Birchall	20,000	€55.9	0%	no data